Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study demonstrated that DA and its oxidative metabolites: H2O2 and aminochrome (AM), cyclized DA quinones, could all directly inhibit
proteasome
activity. DA and AM, especially AM, could induce intensive and irreversible
proteasome
inhibition, whereas
proteasome
inhibition induced by H2O2 was weaker and GSH reversible. It was concluded that DA induced irreversible
proteasome
inhibition via DA-derived quinones, rather than through small molecular weight ROS. The AM was also more toxic than H2O2 to dopaminergic MN9D cells. Furthermore the cytotoxicity and
proteasome
inhibition induced by DA, AM and H2O2 could be abrogated by GSH, ascorbic acid (AA),
Vitamin E
, SOD (superoxidase dismutase) or CAT (catalase) with different profiles. Only GSH was potent to abrogate DA, AM or H2O2-induced cell toxicity and
proteasome
inhibition, as well as to reverse H2O2-induced proteosome inhibition. Therefore, therapeutic strategies to increase GSH level or to use GSH substitutes should function to control PD onset and development.
...
PMID:Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones. 1929 91